| P50 | author | Tushar Kanti Maiti | Q88055369 |
| P2093 | author name string | Pranita Hanpude | |
| | Sushmita Bhattacharya | |
| P2860 | cites work | Gain of function of mutant p53 by coaggregation with multiple tumor suppressors | Q57670523 |
| | Emerging Anatomy of the BAP1 Tumor Suppressor System | Q58236865 |
| | Protein stability versus function: effects of destabilizing missense mutations onBRCA1DNA repair activity | Q64461858 |
| | Autodeubiquitination protects the tumor suppressor BAP1 from cytoplasmic sequestration mediated by the atypical ubiquitin ligase UBE2O | Q24293775 |
| | Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUB | Q24309403 |
| | The deubiquitinating enzyme BAP1 regulates cell growth via interaction with HCF-1. | Q24323060 |
| | Association of C-terminal ubiquitin hydrolase BRCA1-associated protein 1 with cell cycle regulator host cell factor 1 | Q24329078 |
| | BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization | Q24337105 |
| | BAP1 is phosphorylated at serine 592 in S-phase following DNA damage | Q24339530 |
| | Frequent mutation of BAP1 in metastasizing uveal melanomas | Q24601069 |
| | The ubiquitin carboxyl hydrolase BAP1 forms a ternary complex with YY1 and HCF-1 and is a critical regulator of gene expression | Q24633127 |
| | Germline BAP1 mutations predispose to malignant mesothelioma | Q24635326 |
| | Thermodynamic stability of wild-type and mutant p53 core domain | Q24648879 |
| | Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins | Q28281645 |
| | BAP1 protein loss by immunohistochemistry: a potentially useful tool for prognostic prediction in patients with uveal melanoma | Q30457154 |
| | Conditional expression of Parkinson's disease-related R1441C LRRK2 in midbrain dopaminergic neurons of mice causes nuclear abnormalities without neurodegeneration | Q30653185 |
| | Further evidence for germline BAP1 mutations predisposing to melanoma and malignant mesothelioma | Q30654878 |
| | Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas | Q33581027 |
| | The forkhead transcription factor FOXK2 acts as a chromatin targeting factor for the BAP1-containing histone deubiquitinase complex | Q33698585 |
| | A molecular revolution in uveal melanoma: implications for patient care and targeted therapy | Q33717375 |
| | Loss of BAP1 protein expression is an independent marker of poor prognosis in patients with low-risk clear cell renal cell carcinoma | Q33821055 |
| | Disease-causing missense mutations in actin binding domain 1 of dystrophin induce thermodynamic instability and protein aggregation | Q34006640 |
| | Missense mutations in dystrophin that trigger muscular dystrophy decrease protein stability and lead to cross-beta aggregates | Q34093884 |
| | Protein folding in the cytoplasm and the heat shock response | Q34152827 |
| | The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma | Q34190027 |
| | BAP1 loss defines a new class of renal cell carcinoma | Q34280223 |
| | A novel germline mutation in BAP1 predisposes to familial clear-cell renal cell carcinoma. | Q34413144 |
| | Alzheimer presenilin-1 mutations dramatically reduce trimming of long amyloid β-peptides (Aβ) by γ-secretase to increase 42-to-40-residue Aβ. | Q34467478 |
| | A recurrent mutation in PARK2 is associated with familial lung cancer | Q35059365 |
| | Effects of heat shock, heat shock protein 40 (HDJ-2), and proteasome inhibition on protein aggregation in cellular models of Huntington's disease | Q35084195 |
| | Propagation of aggregated p53: Cross-reaction and coaggregation vs. seeding | Q35134517 |
| | Mechanism of initiation of aggregation of p53 revealed by Φ-value analysis | Q35134797 |
| | Regulators of homologous recombination repair as novel targets for cancer treatment. | Q35200273 |
| | Development of cancer-initiating cells and immortalized cells with genomic instability | Q35205699 |
| | α-Synuclein-mediated inhibition of ATF6 processing into COPII vesicles disrupts UPR signaling in Parkinson's disease | Q35569310 |
| | MEK guards proteome stability and inhibits tumor-suppressive amyloidogenesis via HSF1. | Q36041862 |
| | Mutant p53 aggregates into prion-like amyloid oligomers and fibrils: implications for cancer. | Q36201740 |
| | Evaluating Drosophila p53 as a model system for studying cancer mutations | Q36492803 |
| | Germline BAP1 mutations predispose to renal cell carcinomas | Q36909238 |
| | BAP1 and cancer | Q37221089 |
| | Tumor suppressor and deubiquitinase BAP1 promotes DNA double-strand break repair | Q37474898 |
| | Loss of the tumor suppressor BAP1 causes myeloid transformation | Q37545704 |
| | Tumours associated with BAP1 mutations. | Q38070634 |
| | The complex function of hsp70 in metastatic cancer. | Q38173257 |
| | Prion-like aggregation of mutant p53 in cancer | Q38207799 |
| | Targeting heat shock proteins in metastatic castration-resistant prostate cancer | Q38289945 |
| | Amyloidogenicity of p53: a hidden link between protein misfolding and cancer | Q38360401 |
| | Structure based aggregation studies reveal the presence of helix-rich intermediate during α-Synuclein aggregation | Q38898283 |
| | Mutant p53 reprograms TNF signaling in cancer cells through interaction with the tumor suppressor DAB2IP. | Q38934179 |
| | Germline mutations in BAP1 impair its function in DNA double-strand break repair | Q38988548 |
| | Amyloid-like aggregates sequester numerous metastable proteins with essential cellular functions | Q39610788 |
| | Implication of necrosis-linked p53 aggregation in acquired apoptotic resistance to 5-FU in MCF-7 multicellular tumour spheroids | Q39698063 |
| | Induction of Hsp90 protein expression in malignant melanomas and melanoma metastases | Q40580807 |
| | Tumorigenic mutations in VHL disrupt folding in vivo by interfering with chaperonin binding | Q40613613 |
| | Breast cancer risk and possible mechanisms of radiation-induced genomic instability in the Swedish hemangioma cohort after reanalyzed dosimetry | Q41118614 |
| | BRCA1-associated protein 1 (BAP1) deubiquitinase antagonizes the ubiquitin-mediated activation of FoxK2 target genes | Q41752870 |
| | Mutation frequencies of GNAQ, GNA11, BAP1, SF3B1, EIF1AX and TERT in uveal melanoma: detection of an activating mutation in the TERT gene promoter in a single case of uveal melanoma | Q41881966 |
| | Germline BAP1 mutations predispose also to multiple basal cell carcinomas. | Q42463261 |
| | Clinical and pathological impact of VHL, PBRM1, BAP1, SETD2, KDM6A, and JARID1c in clear cell renal cell carcinoma. | Q43806776 |
| | Fibrillar aggregates of the tumor suppressor p53 core domain | Q44528743 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 18462 | |
| P577 | publication date | 2015-12-18 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Cancer associated missense mutations in BAP1 catalytic domain induce amyloidogenic aggregation: A new insight in enzymatic inactivation | |
| P478 | volume | 5 | |